Trial Profile
Pivotal bioequivalence trial of glucagon, delivered by the Glucagon Emergency Management (GEM) system
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 20 Jan 2017
Price :
$35
*
At a glance
- Drugs Glucagon (Primary)
- Indications Hypoglycaemia
- Focus Pharmacokinetics; Registrational
- Sponsors Biodel
- 15 Dec 2014 New trial record
- 04 Dec 2014 This design of this trial and the comparator selected will be based on data from a phase I crossover trial in volunteers (clinical trial 700252270), according to a Biodel media release.